Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal malignancy known, with an extremely poor prognosis due to the lack of an efficient diagnostic scheme and no radical treatment option, except surgery. Therefore, understanding the pathophysiology of, and finding a novel biomarker to detect, P...

Descripción completa

Detalles Bibliográficos
Autores principales: Komura, Takuya, Takabatake, Hisashi, Harada, Kenichi, Yamato, Masatoshi, Miyazawa, Masaki, Yoshida, Keiko, Honda, Masao, Wada, Takashi, Kitagawa, Hirohisa, Ohta, Tetsuo, Kaneko, Shuichi, Sakai, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666027/
https://www.ncbi.nlm.nih.gov/pubmed/28898495
http://dx.doi.org/10.1111/cas.13396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666027/
https://www.ncbi.nlm.nih.gov/pubmed/28898495
http://dx.doi.org/10.1111/cas.13396

Ejemplares similares